Anti-HIV-1 activity of calanolides used in combination with other mechanistically diverse inhibitors of HIV-1 replication.

about

Anti-HIV-1 activity of calanolides used in combination with other mechanistically diverse inhibitors of HIV-1 replication.

Item

http://www.wikidata.org/entity/Q40834269

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年学术文章

@wuu

2000年学术文章

@zh-cn

2000年学术文章

@zh-hans

2000年学术文章

@zh-my

2000年学术文章

@zh-sg

2000年學術文章

@yue

2000年學術文章

@zh

2000年學術文章

@zh-hant

name

Anti-HIV-1 activity of calanol ...... hibitors of HIV-1 replication.

@en

type

Item

label

Anti-HIV-1 activity of calanol ...... hibitors of HIV-1 replication.

@en

prefLabel

Anti-HIV-1 activity of calanol ...... hibitors of HIV-1 replication.

@en

P1476

Anti-HIV-1 activity of calanol ...... hibitors of HIV-1 replication.

@en

P2093

J D Russell

http://www.w3.org/2001/XMLSchema#string

M Flavin

http://www.w3.org/2001/XMLSchema#string

R W Buckheit

http://www.w3.org/2001/XMLSchema#string

Z Q Xu

http://www.w3.org/2001/XMLSchema#string

P2860

The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum

Plant-derived and semi-synthetic calanolide compounds with in vitro activity against both human immunodeficiency virus type 1 and human cytomegalovirus

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

CD4-Pseudomonas exotoxin hybrid protein blocks the spread of human immunodeficiency virus infection in vitro and is active against cells expressing the envelope glycoproteins from diverse primate immunodeficiency retroviruses.

Synthesis, chromatographic resolution, and anti-human immunodeficiency virus activity of (+/-)-calanolide A and its enantiomers.

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.

A three-dimensional model to analyze drug-drug interactions.

HIV-1 drug resistance in newly infected individuals.

Recombinant retroviral systems for the analysis of drug resistant HIV.

In vivo anti-HIV activity of (+)-calanolide A in the hollow fiber mouse model.

P304

321-327

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/095632020001100502

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2000-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12185893

http://www.w3.org/2001/XMLSchema#string

P698

11142630

http://www.w3.org/2001/XMLSchema#string

P921

HIV

(-)-calanolide B